NCT03883022 is a NA clinical trial of with U-VANCO (vancomycin hydrochloride) in Spinal Fusion, sponsored by Taipei Veterans General Hospital, Taiwan.

Who is sponsoring NCT03883022?

NCT03883022 is sponsored by Taipei Veterans General Hospital, Taiwan.

What drugs are being tested in NCT03883022?

Interventions in NCT03883022: with U-VANCO (vancomycin hydrochloride), without U-VANCO (vancomycin hydrochloride).

What condition does NCT03883022 study?

NCT03883022 studies Spinal Fusion, Spinal Stenosis, Spondylolisthesis.

Is NCT03883022 still recruiting?

NCT03883022 is currently recruiting now. Last updated 20 March 2019.

Last reviewed 2019-03-20 · How we verify

NCT03883022

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Vancomycin Powder Combined With Autogenous Bone Graft as a Prevention for Post-operative Infection for Spine Surgery

Recruiting now NA Last updated 20 March 2019

What this trial tests

NA trial testing with U-VANCO (vancomycin hydrochloride) in Spinal Fusion in 400 participants. Currently enrolling.

Timeline

3 September 2018

Primary endpoint
12 September 2027

31 December 2027

Quick facts

Lead sponsor	Taipei Veterans General Hospital, Taiwan
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	prevention
Enrollment	400
Start date	3 September 2018
Primary completion	12 September 2027
Estimated completion	31 December 2027
Sites	1 location across Taiwan

Drugs / interventions tested

with U-VANCO (vancomycin hydrochloride) — full drug profile →
without U-VANCO (vancomycin hydrochloride) — full drug profile →

Conditions studied

Spinal Fusion — all drugs for Spinal Fusion →
Spinal Stenosis — all drugs for Spinal Stenosis →
Spondylolisthesis — all drugs for Spondylolisthesis →

Sponsor

Taipei Veterans General Hospital, Taiwan

Who can join

20 and older, any sex, with Spinal Fusion or Spinal Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Deep surgical site infection (DSSI) is one of the most challenging complications for spinal surgeons and can lead to a poor clinical outcome. This ambispective study was designed to examine the effect of vancomycin powder mixed with autogenous bone graft and bone substitute on preventing deep surgical site infection (DSSI) in degenerative lumbar fusion surgeries as well as any interference with bony fusion.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Vancomycin powder mixed with autogenous bone graft and bone substitute may decrease the deep surgical site infections in elective lumbar instrumented fusion surgery for degenerative disorders: a prospective randomized study.
Wang ST, Lin HH, Yao YC, Huang N, et al · · 2025 · cited 1× · PMID 40334989 · DOI 10.1016/j.spinee.2025.05.001

Verify or expand the search:

Other recruiting trials for Spinal Fusion

Currently open trials in the same condition.

NCT07217873 — IntraVenous Iron in Kids With Iron Deficiency and Scoliosis Study · Phase 2, PHASE3 · recruiting
NCT06471348 — Postoperative Pain Control in AIS Using Liposomal Bupivacaine vs. 0.25% Bupivacaine With Epinephrine · NA · recruiting
NCT06368245 — Durability of Suppl. Rod Constructs-SuppleMentAry Rod Technique for Long-segment Posterior Instrumented Spinal Fusions · recruiting
NCT06603831 — Clinical Evaluation and Cost-effectiveness Analysis of 3D Digital Surgery in Traumatology · NA · recruiting
NCT06020417 — Pedicle Screw Malposition in Spine Arthrodesis Surgeries With O-ARM-guided Navigation · NA · recruiting

Other Taipei Veterans General Hospital, Taiwan trials

Trials by the same sponsor.

NCT07463443 — Effectiveness of Chatbot for Improving Caregiving Outcomes in Primary Caregivers of Geriatric Pneumonia Patients: A Stud · NA · not yet recruiting
NCT07400757 — Statin and Vitamin D Treatment in Patients With Thyroid Eye Disease · NA · not yet recruiting
NCT07362134 — Pulsed-Field Ablation for Recurrent Atypical Atrial Flutter · NA · enrolling by invitation
NCT07473687 — Feasibility Study of Non-Contact Imaging-Based Physiological Monitoring in the Operating Room · recruiting
NCT07344207 — GUARD-PH: Guided Use of AI-ECG for Risk Detection of PH in Surgery (GUARD-PH Trial) · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03883022 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Taipei Veterans General Hospital, Taiwan
Last refreshed: 20 March 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03883022.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing